Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 September 2020 | Story Andre Damons | Photo Charl Devenish
Faculty of Health Sciences donation of PPEs
A group of medical students pose with their new masks, a donation by an alumnus of the Faculty of Health Sciences.

The Faculty of Health Sciences at the University of the Free State (UFS) welcomed the generous donation of 1 000 surgical masks by one of its alumni to aid medical students in this faculty with their clinical training. 

The Professional Provident Society (PPS), a financial services company focused solely on providing intelligent financial solutions for graduate professionals, also donated personal protective equipment (PPE) to the Faculty of Health Sciences.
The first donation was made by Dr Riaan Flooks, a Specialist Physician at Mediclinic Bloemfontein. Dr Flooks received the masks from a friend and decided to donate some of the masks to the UFS. 

Thankful for donations 

Prof Gert van Zyl, Dean: Faculty of Health Sciences, says they are thankful for the donations. 
“All donations help, big or small, and it will help our students to do their tasks and to help where necessary,” Prof Van Zyl said about the second donation by PPS. 
Prof Nathaniel Mofolo, Head: School of Clinical Medicine, expressed his gratitude to Dr Flooks and called him a patron of the university and the faculty.
“On behalf of the School of Clinical Medicine, I hereby wish to express our heartfelt gratitude for your generous contribution and support. This comes at the most needed time and will go a long way in assisting us,” said Prof Mofolo.  
Dr Lynette van der Merwe, undergraduate medical programme director in the School of Clinical Medicine at the University of the Free State (UFS), added that the donation of essential PPE to students for use during training in the clinical areas was much appreciated.  
“The support for the academic programme in a practical, tangible way is highly valuable, as it will assist in protecting students while they are in clinical training.”

Doing their bit

According to PPS, one of the positives of the COVID-19 pandemic is the contributions of so many to deal with the crisis – from individuals to big corporates – who want little or nothing in return.  
“We all need to do our bit, and the PPS board has recently decided to contribute R25 million to fight the pandemic in South Africa. In deciding where this would make the biggest impact, our unique positioning among professionals and our relationship with professional associations were considered.”  
“We are also very conscious that health professionals, in particular, are the front-line soldiers in this war, and need to be protected.  It was therefore decided that a major portion of the money will be used to purchase personal protective equipment (PPE) for the safety of medical professionals in both the public and private sectors,” according to PPS.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept